Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page
- CheckyesterdayChange DetectedRevision: v3.3.4 has been added and Revision: v3.3.3 has been removed. This is a versioning update with no substantive changes to the study record.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedAdded a consolidated Locations section listing study sites across the United States, Canada, Australia, and other countries. Removed several locale-specific location blocks in favor of the unified locations listing.SummaryDifference2%

- Check51 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2 on the Study Details page. No substantive content changes to the study information are evident.SummaryDifference0.0%

- Check58 days agoChange DetectedThe Publications note text was updated to reflect auto-filled PubMed entries with new phrasing. There are no changes to study details or statuses.SummaryDifference0.0%

- Check65 days agoChange DetectedA new study site entry for Tainan, Taiwan was added and the existing Tainan City, Taiwan entry was removed.SummaryDifference0.1%

- Check79 days agoChange DetectedNo significant additions or deletions were detected. The page content appears unchanged.SummaryDifference0.1%

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.